DIAGNOSTICS THROUGH MICROARRAY POSTNATAL DIAGNOSIS

Size: px
Start display at page:

Download "DIAGNOSTICS THROUGH MICROARRAY POSTNATAL DIAGNOSIS"

Transcription

1 DIAGNOSTICS THROUGH MICROARRAY POSTNATAL DIAGNOSIS

2 COMPANY PROFILE Microgenomics S.r.l. is a spin-off company of the University of Pavia founded by the research team of Molecular Cytogenetics of the Department of Molecular Medicine. The Microgenomics laboratory is a highly specialized diagnostic center providing molecular investigation services based on the array-cgh technology. Specialists working in the Microgenomics laboratory are considered, in Italy and abroad, leading experts in the fields of molecular cytogenetics, genomics and microarray analysis, as shown by the numerous publications in major scientific journals and the lectures, on invitation, at the most prestigious international scientific conferences on genetics. R&D activity is an essential element of Microgenomics laboratory. The aims of which are qualitative excellence, implementation of new diagnostic technologies and optimization of those already used in the laboratory. ARRAY-CGH The array-based Comparative Genomic Hybridization (array-cgh or molecular karyotype) is a molecular cytogenetic technique developed to identify Copy Number Variants (CNVs), such as deletions (loss of genomic portions) and amplifications (presence of extra copies of DNA segments), which may be responsible for malformative syndromes, mental retardation, autism, epilepsy and cancer. Array-CGH can detect genomic deletions or amplifications with far greater sensitivity ( times) than can be achieved by conventional chromosome analysis. The Microgenomics laboratory uses high resolution, oligonucleotide-based array- CGH technique for genomic investigations aimed to identify possible disease causing genomic alterations.

3 SERVICES POSTNATAL DIAGNOSIS Nowadays molecular karyotyping is considered a first-tier diagnostic test for individuals with unexplained mental retardation, developmental delay, autism spectrum disorders, epilepsy or multiple congenital anomalies. It has been demonstrated that molecular karyotype guarantees a much higher diagnostic yield (15%-20%) than conventional karyotype (~3%). Microgenomics utilizes different types of array platforms including genomewide arrays, ISCA arrays, and the MicrogenChip arrays developed by this laboratory. Both ISCA and MicrogenChip arrays can detect pathogenic imbalances throughout the genome but can also investigate disease-genes with very high resolution, increasing the sensitivity of the test. The MicrogenChip 180K and MicrogenChip 180K CGH+SNP arrays have been specifically designed for the application of molecular karyotype in postnatal diagnosis. These platforms are continuously updated with new disease genes in order to improve the sensitivity of the array-cgh analysis. MicrogenChip 180K array allows investigation at high resolution of about 500 genomic regions, including telomeric and pericentromeric regions and more than 390 loci associated with congenital malformations and syndromic mental retardation. MicrogenChip 180K CGH+SNP array contains SNP probes that allow to identify uniparental disomies, LOH and low-grade mosaicisms.

4 MICROGENCHIP 180K LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM 1p36 GABRD Idiopathic generalized epilepsy q23 BMPR1A Cowden p36 SKI 1p36 Microdeletion q23 PTEN PTEN-related disorders p36 TP73 1p36 Microdeletion q23 SLC16A12 1p36 KCNAB2 Focal epilepsy q23 LGI1 Cataract, juvenile, with microcornea A and glucosuria Autosomal dominant lateral temporal lobe epilepsy (ADLTE) p34 SLC2A1 Glucose transport defect q24 Split hand and foot malformation p34 POMGNT1 MDDGA q24 FGF8 Hypogonadotropic hypogonadism p33 AGBL4 Autism q25 SMC3 Cornelia de Lange p31 NFIA NFIA haploinsufficiency q26 EMX2 Schizencephaly p21 COL11A1 Stickler p15 Beckwith-Wiedemann / Silver-Russell p12 NOTCH2 Alagille p15 SOX6 Craniosynostosis q21 Thrombocytopenia absent radius p15 ABCC8 Familial hyperinsulinemic hypoglycemia q21 1q21.1 recurrent microdeletion/ microduplication / p15 USH1C Ushers 1C q21 CHRNB2 Nocturnal frontal lobe epilepsy type p13 WAGR q22 1q25 LMNA LHX4 Emery-Dreifuss muscular dystrophy / Werner /Hutchinson-Gilford Progeria Pituitary hormone deficiency, combined, p13- p14 PAX6 Aniridia p13 WT1 Wilms tumor q32 IRF6 Van der Woude p11 Potocki-Shaffer q41 DISP1 Fryns q13 NRXN2 Autism 1q42 TBCE Hypoparathyroidism retardation dysmorphism q13 NDUFV1 Mitochondrial complex I deficiency p14 GATA3 Hypoparathyroidism, sensorineural deafness, and renal disease q13 SHANK2 Autism q11 RET Hirschsprung disease plus q13 DHCR7 Smith-lemli-opitz q11 10q11.2 deletion 11q14 FZD4 Exudative vitreoretinopathy q21 EGR2 Autism q24 CDON Holoprosencephaly q22 KCNMA1 Generalized epilepsy and paroxysmal dyskinesia q24 KIRREL

5 LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM 11q24 KCNJ1 Bartter q22 SIX1 Branchiootorenal p13 CACNA1C Timothy q32 14q32.2 imprinted region paternal and maternal upd(14)- like phenotypes p13 GRIN2B Mental retardation, epilepsy q32 DYNC1H1 Charcot-Marie-Tooth disease type q13 COL2A1 Stickler q11- q13 15q11.2 deletion syndrome 12q13 TUBA1A/ TUBA1B Lissencephaly q11- q13 Angelman / Prader Willi / q13 MLL2 Kabuki q13 15q13.3 Microdeletion q14 LEMD3 Osteopoikilosis q21 SLC12A1 Bartter q24 PTPN11 Noonan q21 FBN1 Marfan q14 TBX5 Holt-Oram q24 15q24 Microdeletion q24 TBX3 Ulnar-mammary q26 CHD2 Scoliosis + CHARGE-like q12 GJB2 Deafness q26 NR2F2 Congenital diaphragmatic hernia q12 B3GALTL Peters-plus q25 IGF1R IGF-1 resistance q13 RXFP2 Cryptorchidism, unilateral or bilateral p13 HBA1& HBA2 Alpha thalassemia mental retardation q14 RB1 Retinoblastoma p13 CACNA1H Idiopathic generalized epilepsy q14 ATP7B Wilson disease p13 TSC2 Tuberous sclerosis q22 EDNRB Hirschsprung disease plus p13 PKD1 Polycystic kidney disease q32 ZIC2 Holoprosencephaly p13 CREBBP Rubinstein-Taybi q11 CHD8 Autism p13 A2BP1 Epilepsy, mental retardation q12 FOXG1 Rett, congenital variant p13 GRIN2A Mental retardation, epilepsy q13 PAX9 Selective tooth agenesis p13 16p13.1 Microdeletion predisposition to autism 14q22 BMP4 Microphthalmia with brain and digital anomalies p11- p12 16p11.2-p12.2 Microdeletion/ microducplication q22 OTX2 Microphthalmia syndromic p11 16p11.2 Microdeletion/microducplication q22 SIX6 Microphthalmia q12 SALL1 Townes brocks

6 LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM 16q13 GPR56 Bilateral frontoparietal polymicrogyria p13 STK11 Peutz-Jeghers q21 CDH8 Autism p13 NOTCH3 CADASIL q22 CBFB Delayed cranial ossification q13 SCN1B Generalized epilepsy with febrile seizures plus q24 CDH q13 RPS19 Diamond blackfan anemia q24 ANKRD11 KBG syndrome p24 MYCN Feingold p13 ASPA Canavan p22 SOS1 Noonan p13 Miller-Dieker p21 Cystinuria with mitochondrial disease p13 TP53 Li-Fraumeni p21 SIX3 Holoprosencephaly p12 PMP22 Charcot marie tooth disease 1A p16 NRXN1 Autism p11 RAI1 Smith-magenis p15 2p15-p16.1 Microdeletion q11 NF1 Neurofibromatosis Type q14 GLI2 Holoprosencephaly q12 HNF1B Reanal cysts and diabetes q22 ZEB2 Mowat-Wilson q21 SOST Sclerosteosis q23 MBD5 Mental retardation q21 17q21.31Microdeletion q23 CACNB4 Idiopathic generalized epilepsy type q21 COL1A1 Osteogenesis imperfecta q24 SLC4A10 Autism, epilepsy, mental retardation q24 Pierre Robin/sex reversal/cooks/ campomelic dysplasia / / q24 SCN3A Infantile epilepsy q24 SOX9 Campomelic dysplasia q24 SCN2A Early infantile epileptic encephalopathy type q25 CSNK1D/ SLC16A3 Autism q24 SCN1A SCN1A related seizures p31 TGIF1 Holoprosencephaly q24 SCN9A Generalized epilepsy with febrile seizures plus q12 SETBP1 Schinzel-Giedion q31 SLC25A12 Hypomyelination, global, cerebral q21 DYM Dyggve-Melchior-Clausen disease q31 EVX2 Synpolydactyly q21 SMAD4 Hereditary hemorrhagic telangiectasia q31 HOXD gene cluster q21 TCF4 Pitt-Hopkins q32 SATB2 Cleft palate

7 LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM 2q33 BMPR2 Primary pulmonary hypertension p25 VHL Von hippel lindau q36 PAX3 Waardenburg p25 RAF1 Noonan q37 HDAC4 Brachydactyly-mental retardation p24 TGFBR2 Marfan q37 KIF1A p21 TDGF1 Mental retardation and holoprosencephaly p12 JAG1 Alagille p14 MITF Waardenburg IIA q11 ASXL1 Bohring-Opitz syndrome p13 FOXP1 20q11 GDF5 Brachydactyly type C q21 CASR 20q11 EPB41L1 11 Intellectual disability, autism, and language impairment Autosomal dominant hypocalciuric hypocalcemia q22 FOXL2 BPES q13 SALL4 Okihiro q24 SLC9A9 Autism q13 GNAS Albright hereditary osteodystrophy q24 c3orf58 Autism q13 CHRNA4 Nocturnal frontal lobe epilepsy type q24 ZIC4/ZIC1 Dandy-Walker q13 KCNQ2 Familial neonatal seizures type q26 PDCD10 Cerebral cavernous malformations type 3 (CCM3) q21 GRIK1 Juvenile absence epilepsy type q26 SOX2 Microphthalmia q21 22q11 DYRK1A 7 DGVCF/Microduplication q27 CLCN / q28 TP63 ADULT/EEC3 Idiopathic generalized epilepsy type / q11 TBX1 digeorge q29 3q29 Microdeletion/microduplication q12 NF2 Meningioma/NF / p16 FGFR3 Muenke/achondroplasia/thanatophoric dysplasia type I (TD1) / / MICROGENCHIP 180K 22q12 CACNG p16 WHSC1 Wolf-hirschhorn q13 SOX10 Waardenburg 4C p16 WHSC2 Wolf-hirschhorn q13 EP300 Rubinstein-Taybi p16 PPP2R2C Mental retardation, epilepsy q13 22q13 Microdeletion (Phelan McDermid) q22 PKD2 Polycystic kidney disease q13 SHANK3 Autism, mental retardation q25 PITX2 Rieger

8 MICROGENCHIP 180K LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM 5p13 NIPBL Cornelia de Lange p14 GLI3 Greig cephaloplysindactyly q14 MEF2C Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations p13 CCM2 Cerebral cavernous malformations type 2 (CCM2) q14 GPR98 Familial febrile seizures type p12 GRB10 Silver-Russell q22 APC Gardner q11 5q23 LMNB1 Adult-onset autosomal dominant leukodystrophy Williams-Beuren microdeletion/ microduplication q11 7q11.23 Distal Deletion q32 SPINK1 Chronic pancreatitis q21 MAGI2 Infantile spasms q33 TCOF1 Treacher Collins q21 KRIT1 Cerebral cavernous malformations type 1 (CCM1) q34 GABRA1 Juvenile myoclonic epilepsy type q21 COL1A2 Ehlers-danlos q34 5q35 GABRG2 FBXW11 Familial febrile seizures type 8/ childhood absence epilepsy type 2 Holoprosencephaly and preaxial polydactly / q35 MSX2 Craniosynostosis q22 RELN 7q21 SGCE Myoclonic dystonia q21 Split hand and foot malformation Lissencephaly with cerebellar hypoplasia q35 NSD1 Sotos q31 FOXP2 Verbal dyspraxia p25 TUBB2B Asymmetric polymicrogyria q31 KCND2 Temporal lobe epilepsy p24 FOXC1 6p24 Deletion q31 CADPS2 Autism p21 6p21 SYNGAP1 VEGFA 5 Vascular endothelial growth factor disorders q35-36 CNTNAP2 Autism q36 EN2 Autism p21 RUNX2 Cleidocranial dysplasia q36 SHH Holoprosencephaly p12 6q16 EFHC1 GRIK2 Juvenile absence epilepsy type 1/ juvenile myoclonic epilepsy type 1 Mental retardation, autosomal recessive / q36 LMBR1 Polydactyl preaxial q36 MNX1 Currarino q24 PLAGL1 Diabetes mellitus, transient neonatal, p23 DLGAP2 Autism p21 TWIST1 Saethre-Chotzen p23 GATA4 Congenital heart defects

9 LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM 8p21 CHRNA2 Nocturnal frontal lobe epilepsy type Xp22 PAR1 8p12 FGFR1 Kallmann Xp22 SHOX Leri-Weill dyschondrostosis (LWD) - SHOX deletion q12 CHD7 CHARGE Xp22 ARSE Chondrodysplasia punctata X-linked q13 EYA1 Branchio-oto-renal Xp22 NLGN4 Autism, mental retardation q21 8q21.11 Microdeletion Syndrome Xp22 STS Steroid sulfatase q23 ZFPM2 Diaphragmatic hernia Xp22 KAL1 Kallmann q23 TRPS1 Trichorhinophalangeal Xp22 HCCS Microphthalmia with linear skin defects q24 EXT1 Trichorhinophalangeal 2 (Langer- Giedion) Xq22 MID1 Opitz q24 KCNQ3 Familial neonatal seizures type Xp22 OFD1 Orofaciodigital q24 KCNK9 Birk-barel mental retardation dysmorphism Xp22 AP1S2 X-linked mental retardation p24 DMRT1 9p24 Microdeletion Xp22 NHS Nance-horan p24 DMRT2 9p24 Microdeletion Xp22 CDKL5 early infantile epileptic encephalopathy q22 PTCH1 Holoprosencephaly Xp22 PDHA1 Pyruvate decarboxylase deficiency q22 TGFBR1 Loeys-Dietz Xp22 RPS6KA3 Coffin-lowry q33 NR5A1 XY Sex Reversal Xp22 SMS Snyder-Robinson q33 LMX1B Nail-patella Xp22 PHEX Hypophosphatemic rickets q34 STXBP1 Early infantile epileptic encephalopathy Xp22 DDX53/ PTCHD1 Autism q34 ENG Hereditary hemorrhagic telangiectasia Xp21 ARX Early infantile epileptic encephalopathy q34 SPTAN1 Early infantile epileptic encephalopathy type Xp21 IL1RAPL1 X-linked mental retardation q34 TSC1 Tuberous sclerosis Xp21 NR0B1 Adrenal hypoplasia congenita q34 POMT1 MDDGA Xp21 GK Glycerol kinase deficiency q34 GRIN Xp21 DMD Duchenne muscular dystrophy q34 EHMT1 9q34.3 Microdeletion CYBB Chronic granulomatous disease

10 LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM OTC Ornithine transcarbamylase deficiency PHF8 Syndromic X-linked mental retardation, Siderius type TSPAN7 X-linked mental retardation FGD1 Aarskog-Scott BCOR Syndromic microphthalmia Xq11 ARHGEF9 Hyperekplexia and epilepsy ATP6AP2 X-linked mental retardation with epilepsy Xq12 AR Androgen insensitivity CASK MICPCH Xq12 OPHN1 X-linked mental retardation, with cerebellar hypoplasia and distinctive facial appearance MAOA Brunner Xq13 EFNB1 Craniofrontonasal NDP Norrie Xq13 EDA Ectodermal dysplasia ZNF674.3 deletion Xq13 DLG3 X-linked mental retardation RP2.3 deletion Xq13 MED12 Opitz-Kaveggia ZNF41 X-linked mental retardation Xq13 ZMYM3 X-linked mental retardation SYN1 Epilepsy, X-linked, with variable learning disabilities and behavior disorders Xq13 NLGN3 Autism ZNF81 X-linked mental retardation Xq13 SLC16A2 Allan-Herndon-Dudley FTSJ1 X-linked mental retardation Xq13 KIAA2022 X-linked mental retardation p11.22 duplication Xq13 ZDHHC15 X-linked mental retardation PORCN Focal dermal hypoplasia Xq21 ATRX Alpha thalassemia mental retardation PQBP1 Renpenning Xq21 ATP7A Menkes SYP X-linked mental retardation SYP-related Xp21 PGK1 Phosphoglycerate kinase-1 deficiency CLCN5 Nephrolithiasis 2, X-linked/dent disease / Xp21 BRWD3 X-linked mental retardation SHROOM4 Stocco dos Santos X-linked mental retardation Xq21 ZNF711 X-linked mental retardation KDM5C Syndromic X-linked mental retardation JARID1C-related Xp21 CHM Choroideremia SMC1A Cornelia de Lange X-linked Xq22 TIMM8A Deafness-dystonis-optic neuronopathy HSD17B10 HSD10 deficiency/syndromic X- linked mental retardation / Xq22 SRPX2 Rolandic epilepsy, X-linked mental retardation, and speech dyspraxia HUWE1 Syndromic X-linked mental retardation, Turner type Xq22 PCDH19 Early infantile epileptic encephalopathy type

11 LOCUS GENE SYNDROME/DISEASE OMIM LOCUS GENE SYNDROME/DISEASE OMIM Xq22 BTK Agammaglobulinemia, X-linked Xq26 ARHGEF6 X-linked mental retardation Xq22 GLA Fabry disease Xq26 ZIC3 X-linked heterotaxy Xq22 PLP1 Pelizaeus-merzbacher disease Xq27 SOX3 Xq22 PRPS1 Charcot marie tooth disease X-linked Xq22 COL4A5 Alport, X-linked Xq28 EMD Xp22 ACSL4 X-linked mental retardation Xq28 AFF2 X-linked mental retardation with panhypopituitarism Xq27 FMR1 Fragile X Emery-dreifuss muscular dystrophy X-linked mental retardation associated with fragile site FRAXE Xp22 PAK3 X-linked mental retardation Xq28 IDS Hunter, Mucopolysaccharidosis type Xq22- q23 DCX X-linked lissencephaly/subcortical band heterotopia Xq23 AGTR2 X-linked mental retardation Xq28 SLC6A8 Xq23 Xq24 Xq24 UBE2A UPF3B NDUFA1 Syndromic X-linked mental retardation, UBE2A-related Syndromic X-linked mental retardation 14 X-linked mitochondrial complex I deficiency Xq28 MTM1 Myotubular myopathy Creatine deficiency / X-linked mental retardation Xq28 ABCD1 Adrenoleukodystrophy Xq28 L1CAM HSAS, MASA, CRASH Xq28 AVPR2 Diabetes insipidus, nephrogenic, X-linked / Xq24 LAMP2 Danon disease Xq28 MECP2 Rett Xq24 CUL4B X-linked mental retardation with short stature, hypogonadism, and abnormal gait Xq28 FLNA Heterotopia, periventricular, X- linked dominant Xq24 GRIA3 X-linked mental retardation Xq28 RPL10 Autism Xq25 OCRL Lowe Xq28 GDI1 X-linked mental retardation Xq25 ZDHHC9 Syndromic X-linked mental retardation ZDHHC9-related Xq28 IKBKG Incontinentia pigmenti Xq26 GPC3 Simpson, golabi, behmel, type Xq28 DKC1 X-linked dyskeratosis congenita Xq26 PHF6 Borjeson-forssman-lehmann Xq28 RAB39B X-linked mental retardation Xq26 HPRT1 Lesch-Nyhan Xq28 PAR2 Xq26 SLC9A6 X-linked mental retardation, christianson type Yp11 SRY Gonadal dysgenesis SRY-related v. 2.0 (last update: 03/2012) MICROGENCHIP 180K

12 MICROGENOMICS SRL Via Fratelli Cuzio, 42 C/O Polo Tecnologico di Pavia Pavia (PV) - Italy Tel Fax info@microgenomics.it

devseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders

devseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders ACSL4 Mental/retardation,/XBlinked/63 XLBR ADSL Adenylosuccinase/Deficiency AR AFF2 Mental/retardation,/XBlinked,/FRAXE/type XLBR ALG6 Congenital/disorder/of/glycosylation/type/Ic AR ANK3 Mental/retardation,/autosomal/recessive/37

More information

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded

More information

PITTSBURGH CYTOGENETICS LABORATORY

PITTSBURGH CYTOGENETICS LABORATORY PITTSBURGH CYTOGENETICS LABORATORY GENES COVERED BY X-HR AND SYNDROMES DETECTED BY X-HR # GENES LOCI DISORDERS 1 ABCB7 Xq12-q13 Anemia, sideroblastic, with ataxia 2 ABCD1 Xq28 Adrenoleukodystrophy 3 ACSL4

More information

'Translating massively parallel sequencing into clinical diagnostics.

'Translating massively parallel sequencing into clinical diagnostics. 'Translating massively parallel sequencing into clinical diagnostics. SA Pathology at the Women s and and The University of Adelaide Adelaide, Australia MPS is revolutionising genetics & biology - >100

More information

Whole exome sequencing Gene package Hereditary Congenital Defects version 3.1,

Whole exome sequencing Gene package Hereditary Congenital Defects version 3.1, Whole Exome Sequencing Gene package Hereditary Congenital Defects, version 3.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired

More information

Chromosomal Microarray & Microdeletion FISH Panel

Chromosomal Microarray & Microdeletion FISH Panel Chromosomal Microarray & Microdeletion FISH Panel Chromosomal Microarray Chromosomal microarray using array comparative genomic hybridization with single nucleotide polymorphism (array CGH+SNP) testing

More information

MLPA SAMPLES USER GUIDE

MLPA SAMPLES USER GUIDE MLPA SAMPLES USER GUIDE MLPA microdeletion studies Requirements: 1-2 mls (minimum) of peripheral blood in a lithium heparin tube (green or orange top) AND 1-2 mls of peripheral blood in a EDTA tube (purple

More information

Case 1B. 46,XY,-14,+t(14;21)

Case 1B. 46,XY,-14,+t(14;21) Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short

More information

Phone: Referring Provider: NPI #: Referring Laboratory (if different): Physician signature: Name: Name: Address: Address:

Phone: Referring Provider: NPI #: Referring Laboratory (if different): Physician signature: Name: Name: Address: Address: MOLECULAR (DNA) TEST REQUISITION FOR CHG LAB USE ONLY: Center for Human Genetics, Inc. Date received: Riverside Technology Center Pedigree #: 840 Memorial Drive, Suite 101 Family name: Cambridge, MA 02139

More information

Region Chr. Start bp End bp Band Disease OMIM 4x180K 8x60K 4x44K

Region Chr. Start bp End bp Band Disease OMIM 4x180K 8x60K 4x44K ISCA The industry standard ISCA design is followed on the CytoChip ISCA 4x44K, 8x60K and 4x180K arrays. The design includes high density probe coverage of the regions detailed in this table. ISCA design

More information

Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients

Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients Lim et al. Human Genomics (2015) 9:33 DOI 10.1186/s40246-015-0055-x PRIMARY RESEARCH Open Access Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Phone: Address: Address: City State Zip Code City State Zip Code. Phone: Fax: Phone: Fax: Genetic Counselor:

Phone: Address: Address: City State Zip Code City State Zip Code. Phone: Fax: Phone: Fax: Genetic Counselor: MOLECULAR (DNA) TEST REQUISITION FOR CHG LAB USE ONLY: Center for Human Genetics, Inc. Date received: Riverside Technology Center Pedigree #: 840 Memorial Drive, Suite 101 Family name: Cambridge, MA 02139

More information

Role of Molecular Genetic Assessment for Autism in Clinical Setting

Role of Molecular Genetic Assessment for Autism in Clinical Setting Role of Molecular Genetic Assessment for Autism in Clinical Setting Young Shin Kim, MD, MS, MPH, PhD Director STAR Center for ASD and NDDs Psychiatric Genetic Epidemiology Associate Professor Dept. of

More information

Phone: Address: Address: City State Zip Code City State Zip Code. Phone: Fax: Phone: Fax: Genetic Counselor:

Phone: Address: Address: City State Zip Code City State Zip Code. Phone: Fax: Phone: Fax: Genetic Counselor: MOLECULAR (DNA) TEST REQUISITION FOR CHG LAB USE ONLY: Center for Human Genetics, Inc. Date received: Riverside Technology Center Pedigree #: 840 Memorial Drive, Suite 101 Family name: Cambridge, MA 02139

More information

SNP Microarray. Prenatal Disorder List

SNP Microarray. Prenatal Disorder List SM SNP Microarray Prenatal Disorder List Revealing Answers to Complex Questions Reveal SM SNP Microarray is a high density copy number array that can also detect copy neutral changes such as uniparental

More information

ERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague

ERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague ERN EpiCARE A European Reference Network for Rare and Complex Epilepsies Petr Marusic Motol University Hospital, Prague Disclosure I have no actual or potential conflict of interest in relation to this

More information

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia 205 FGFR3 Common mutations in FGFR3 Gene(s) or locus Description of test Category (1138 G>A/C and 1620C>A/G) Adrenal

More information

Beyond Mendel s Laws of Inheritance

Beyond Mendel s Laws of Inheritance Beyond Mendel s Laws of Inheritance 2006-2007 Extending Mendelian genetics Mendel worked with a simple system peas are genetically simple most traits are controlled by a single gene each gene has only

More information

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia 205 FGFR3 Common mutations in FGFR3 Gene(s) or locus Description of test Category (1138 G>A/C and 1620C>A/G) Adrenal

More information

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3

DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 DISEASE / DISORDER Price Routine TAT (Calendar Days) Achondroplasia + Hypochondroplasia 205 FGFR3 Common mutations in FGFR3 Gene(s) or locus Description of test Category (1138 G>A/C and 1620C>A/G) Adrenal

More information

Quick Guide To Genetic Testing

Quick Guide To Genetic Testing Aceruloplasminemia testing CP sequencing 2101 81406 4 weeks $1,000 Aceruloplasminemia CP deletion/duplication 2102 81405 4 weeks $1,000 Albinism testing Albinism Sequencing Panel** 1101 81407 8 weeks $2,500

More information

MAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID

MAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID versie 16-Apr-2018 (59 genen) MAC-ASD panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern ABCB6 605452 [Blood

More information

Quick Guide To Genetic Testing

Quick Guide To Genetic Testing Aceruloplasminemia testing CP sequencing 2101 81406 4 weeks $1,000 Aceruloplasminemia CP deletion/duplication 2102 81405 4 weeks $1,000 Albinism testing Albinism Sequencing ** 1101 81407 8 weeks $2,500

More information

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G)

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G) DISEASE / DISORDER Price Routine TAT (Calendar Days) Gene(s) or locus Description of test (including reference intervals/ clinical decision values where applicable) Category Achondroplasia + Hypochondroplasia

More information

A European Reference Network for rare and complex epilepsies. J Helen Cross Coordinator

A European Reference Network for rare and complex epilepsies. J Helen Cross Coordinator A European Reference Network for rare and complex epilepsies J Helen Cross Coordinator The epilepsies a group of rare diseases Early myoclonic encephalopathy PIGA, SETBP1, SIK1, SLC25A22 Dravet syndrome

More information

The University of Chicago Genetic Services Laboratories

The University of Chicago Genetic Services Laboratories Aceruloplasminemia testing CP sequencing Aceruloplasminemia CP deletion/duplication Albinism testing Albinism Sequencing Panel (20 genes Albinism Deletion/Duplication Panel (20 genes Alstrom syndrome testing

More information

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B

SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B SALSA MLPA probemix P372-B1 Microdeletion Syndromes 6 Lot B1-1016, B1-0613. The purpose of the P372 probemix is to further investigate results found with the P245 Microdeletion Syndromes-1A probemix. The

More information

Get a more complete picture into your patient's pregnancy with PreSeek

Get a more complete picture into your patient's pregnancy with PreSeek PRENATAL Expecting a baby is an exciting and mysterious time. And it s natural for your patient to wonder if they have a healthy pregnancy. Introducing PreSeek, the most comprehensive, single gene, cell-free

More information

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G)

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G) DISEASE / DISORDER Price Routine TAT (Calendar Days) Gene(s) or locus Description of test (including reference intervals/ clinical decision values where applicable) Category Achondroplasia + Hypochondroplasia

More information

Division of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition.

Division of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition. Page 1 of 8 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostics Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 PATIENT

More information

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

Human Genetic Variation Copy Number Variation

Human Genetic Variation Copy Number Variation The Evolution of Laboratory Prenatal Diagnosis Lawrence D. Platt, MD Professor of Obstetrics and Gynecology David Geffen School of Medicine at UCLA Center for Fetal Medicine & Women s Ultrasound Los Angeles,

More information

PGD: A Celebration of 20 years:

PGD: A Celebration of 20 years: PGD: A Celebration of 20 years: What is Reality and What is Not? Roma June 30, 2010 Mark Hughes, M.D., Ph.D. Professor of Genetics, Internal Medicine, Pathology Director, Genesis Genetics Institute Director,

More information

Certificate of Analysis

Certificate of Analysis COA Version 01; Issued on 30 June 2017 (v02) Certificate of Analysis SALSA probemix P064 Microdeletion Syndromes-1B Catalogue # Product name P064-025R, P064-50R, P064-100R Probemix P064 Microdeletion Syndromes-1B

More information

Lions and Tigers and Bears.Oh My!

Lions and Tigers and Bears.Oh My! Lions and Tigers and Bears.Oh My! TAKING THE FEAR OUT OF GENETIC TESTING Lisa Butterfield, MS, CGC Genetic Counselor Clinical Assistant Professor University of Kansas Health System Why is Genetic Testing

More information

Whole exome sequencing Gene package Autism version 2,

Whole exome sequencing Gene package Autism version 2, Whole Exome Sequencing Gene package Autism, version 2, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014 Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical

More information

The first non-invasive prenatal test that screens for single-gene disorders

The first non-invasive prenatal test that screens for single-gene disorders The first non-invasive prenatal test that screens for single-gene disorders the evolution of NIPT A non-invasive prenatal test that screens multiple genes for mutations causing severe genetic disorders

More information

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G)

Achondroplasia + Hypochondroplasia FGFR3 Common mutations in FGFR3 (1138 G>A/C and 1620C>A/G) DISEASE / DISORDER Price Routine TAT (Calendar Days) Gene(s) or locus Description of test (including reference intervals/ clinical decision values where applicable) Category Achondroplasia + Hypochondroplasia

More information

Reproductive Physiology Primordial Germ Cells Yolk Sac Sex Chromosomes Females Males Sex-Linked Traits

Reproductive Physiology Primordial Germ Cells Yolk Sac Sex Chromosomes Females Males Sex-Linked Traits Reproductive Physiology Primordial Germ Cells - from Yolk Sac these migrate to fetus when it is 5 weeks old - these cells give rise to the gonads (ovaries for female, testes for male) first they form the

More information

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509

SALSA MLPA probemix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 mix P371-A1 Microdeletion Syndromes 5 Lot A1-0509 The purpose of the P371 mix is to further investigate results found with the P245 Microdeletion mix. The P245 mix provides a possibility to screen samples

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_epilepsy 1/28/14 10/2017 10/2018 10/2017 Description of Procedure or Service Description

More information

DSD panel. versie V2 (79 genen) Centrum voor Medische Genetica Gent

DSD panel. versie V2 (79 genen) Centrum voor Medische Genetica Gent DSD panel versie V2 (79 genen) Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern AKR1C2 600450 Obesity, hyperphagia,

More information

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray

Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray OGT UGM Birmingham 08/09/2016 Dom McMullan Birmingham Women's NHS Trust WM chromosomal microarray (CMA) testing Population of ~6 million (10%)

More information

What s the Human Genome Project Got to Do with Developmental Disabilities?

What s the Human Genome Project Got to Do with Developmental Disabilities? What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the

More information

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Product Description SALSA Probemix P064-C2 Microdeletion Syndromes-1B To be used with the MLPA General Protocol. Version C2. Small change in sequence of two probes. For complete product history see page

More information

Heterotaxie PCD (Primaire ciliaire dyskinesie) panel

Heterotaxie PCD (Primaire ciliaire dyskinesie) panel Heterotaxie PCD (Primaire ciliaire dyskinesie) panel versie V1 (92 genen) Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance

More information

MRC-Holland MLPA. Description version 24;

MRC-Holland MLPA. Description version 24; SALSA MLPA KIT P245-A2 Microdeletion Syndromes-1 Lot 0909, 0209, 1008. As compared to lot 1207, two extra control fragments at 100 and 105 nt have been added (X and Y-specific). The 108 nt Y probe has

More information

Whole exome sequencing Gene package Autism version 2.1,

Whole exome sequencing Gene package Autism version 2.1, Whole Exome Sequencing Gene package Autism, version 2.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on the Illumina

More information

OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018

OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 Please note that there is a 15% surcharge for Non-NHS patients. Highly specialised services (HSS) are indicated. Note: This test

More information

Whole exome sequencing Gene package Disorders of Sex Development (DSD) version 6,

Whole exome sequencing Gene package Disorders of Sex Development (DSD) version 6, Whole Exome Sequencing Gene package Disorders of Sex Development (DSD), version 6, 30 7 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired

More information

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 Why causation? Explanation for family Prognosis Recurrence risk and reproductive options Guide medical

More information

The Japanese collaborated study of Fragile X syndrome and its related disorders

The Japanese collaborated study of Fragile X syndrome and its related disorders The Japanese collaborated study of Fragile X syndrome and its related disorders Yuji Nakayama, PhD Research Center for Bioscience and Technology, Tottori University, Japan TOTTORI Tsukuba Kyoto TOKYO Okayama

More information

Approach to the Genetic Diagnosis of Neurological Disorders

Approach to the Genetic Diagnosis of Neurological Disorders Approach to the Genetic Diagnosis of Neurological Disorders Dr Wendy Jones MBBS MRCP Great Ormond Street Hospital for Children National Hospital for Neurology and Neurosurgery What is a genetic diagnosis?

More information

Epileptogenesis: A Clinician s Perspective

Epileptogenesis: A Clinician s Perspective Epileptogenesis: A Clinician s Perspective Samuel F Berkovic Epilepsy Research Centre, University of Melbourne Austin Health Epileptogenesis The process of development and sustaining the propensity to

More information

Genetics and Developmental Disabilities. Stuart K. Shapira, MD, PhD. Pediatric Genetics Team

Genetics and Developmental Disabilities. Stuart K. Shapira, MD, PhD. Pediatric Genetics Team Genetics and Developmental Disabilities Stuart K. Shapira, MD, PhD Pediatric Genetics Team National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention The

More information

Introduction to Fetal Medicine: Genetics and Embryology

Introduction to Fetal Medicine: Genetics and Embryology Introduction to Fetal Medicine: Genetics and Embryology Question: What do cancer biology, molecular biology, neurobiology, cell biology developmental biology and reproductive biology, all have in common?

More information

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome

More information

The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician

The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician Part VII Recent Advances in the Genetics of Autism Spectrum Disorders Abha R. Gupta, MD, PhD Jointly

More information

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه

More information

Prevalence of Hearing Impairment

Prevalence of Hearing Impairment Prevalence of Hearing Impairment 28 million Americans 2 million profoundly deaf 1/1000 congenitally deaf 1/3 impaired by age 65 1/2 impaired by age 80 NIDCD National Strategic Research Plan, 1989 Genetic

More information

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Dr. Sarah Weckhuysen, MD, PhD Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Common Prevalence 4-8/1000 Life time incidence 3% Key symptom = seizures Nature Reviews

More information

Microdeletion and Prenatal FISH Probes

Microdeletion and Prenatal FISH Probes Microdeletion and Prenatal FISH Probes Rapid Prenatal Screening The Cytocell prenatal FISH assays are designed for the rapid and accurate detection of the most common foetal chromosomal disorders: Down

More information

Symptoms and diagnosis of autism in individuals with genetic disorders

Symptoms and diagnosis of autism in individuals with genetic disorders Symptoms and diagnosis of autism in individuals with genetic disorders Dr Jane Waite Lecturer and Clinical Psychologist 15 th March 2018 The West Midlands Neurodevelopmental Disorders Network (2018) Overview

More information

DSD panel. 12-Mar-2018 (103 genen) Centrum voor Medische Genetica Gent. versie

DSD panel. 12-Mar-2018 (103 genen) Centrum voor Medische Genetica Gent. versie versie 12-Mar-2018 (103 genen) DSD panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern AKR1C2 600450 Obesity,

More information

Name: Last First Date of Birth (mm/dd/yyyy): Gender: Male Female MRN: Ethnicity: Caucasian African-American Hispanic Asian Ashkenazi Jewish Other

Name: Last First Date of Birth (mm/dd/yyyy): Gender: Male Female MRN: Ethnicity: Caucasian African-American Hispanic Asian Ashkenazi Jewish Other Requisition Form 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax: 773.702.9130 ucgslabs@genetics.uchicago.edu dnatesting.uchicago.edu CLIA#:

More information

Comprehensive Test Menu August 2018

Comprehensive Test Menu August 2018 Comprehensive Test Menu August 2018 Cancer brain tumors Brain tumors, hereditary BrainTumorNext: 27 genes 14-21 days 8847 Neurofibromatosis type 2 (NF2) NF2 14-21 days 9024 Schwannomatosis SMARCB1 14-21

More information

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Dr. Sarah Weckhuysen, MD, PhD Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Sarah Weckhuysen No relevant financial relationships with any commercial interests.

More information

COMPLETE LIST OF GENETIC ANALYSES

COMPLETE LIST OF GENETIC ANALYSES Aarskog-Scott syndrome Achondroplasia Achromatopsia Acromesomelic dysplasia, Maroteaux type Adenosine deaminase deficiency Adrenoleukodystrophy Aicardi-Goutieres syndrome Alagille syndrome Albinism Alkaptonuria

More information

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN

Genomics and Genetics in Healthcare. By Mary Knutson, RN, MSN Genomics and Genetics in Healthcare By Mary Knutson, RN, MSN Clinical Objectives Understand the importance of genomics to provide effective nursing care Integrate genetic knowledge and skills into nursing

More information

Genetics and Genomics: Applications to Developmental Disability

Genetics and Genomics: Applications to Developmental Disability Tuesday, 12:30 2:00, B1 Objective: Genetics and Genomics: Applications to Developmental Disability Helga Toriello 616-234-2712 toriello@msu.edu Identify advances in clinical assessment and management of

More information

Introduction to Fetal Medicine: Genetics and Embryology

Introduction to Fetal Medicine: Genetics and Embryology Introduction to Fetal Medicine: Genetics and Embryology Question: What do cancer biology, molecular biology, neurobiology, cell biology developmental biology and reproductive biology, all have in common?

More information

Dysmorphology And The Paediatric Eye. Jill Clayton-Smith Manchester Centre For Genomic Medicine

Dysmorphology And The Paediatric Eye. Jill Clayton-Smith Manchester Centre For Genomic Medicine Dysmorphology And The Paediatric Eye Jill Clayton-Smith Manchester Centre For Genomic Medicine Why Make A Syndrome Diagnosis? Why did it happen? What does the future hold? How can you treat/manage it?

More information

Why did this happen? Genetic and teratologic considerations in CHD Jennifer Kussmann, MS,CGC. The Children's Mercy Hospital, 2014.

Why did this happen? Genetic and teratologic considerations in CHD Jennifer Kussmann, MS,CGC. The Children's Mercy Hospital, 2014. Why did this happen? Genetic and teratologic considerations in CHD Jennifer Kussmann, MS,CGC The Children's Mercy Hospital, 2014. 03/14 Risk factors Family history Maternal medical condition/ illness Monochorionic

More information

Approach to Intellectual Disability

Approach to Intellectual Disability Approach to Intellectual Disability Dr Prajnya Ranganath Definition Significant sub-average intellectual function existing concurrently with deficits in adaptive behaviour and manifested during the developmental

More information

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi 2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000

More information

Formal Genetics of Humans: Modes of Inheritance. Dr. S Hosseini-Asl

Formal Genetics of Humans: Modes of Inheritance. Dr. S Hosseini-Asl Formal Genetics of Humans: Modes of Inheritance Dr. S Hosseini-Asl 1 Autosomal dominant (AD) a: Wild type (Wt) allele A: Mutant allele aa: Normal phenotype Aa: Affected (heterozygous) AA: Affected (homozygous)

More information

UKGTN Testing Criteria

UKGTN Testing Criteria Test name: Epilepsy 53 Gene Panel UKGTN Testing Criteria Approved name and symbol of disorder/condition(s): Epilepsy Panel Test See Appendix 1 Approved name and symbol of gene(s): See Appendix 2 OMIM number(s):

More information

Unusual Modes of Inheritance. Wayne Lam

Unusual Modes of Inheritance. Wayne Lam Unusual Modes of Inheritance Wayne Lam wayne.lam@ed.ac.uk New Genetics Non-Mendelian Genomic Imprinting Digenic Inheritance Triallelic inheritance Mitochondrial Inheritance Chromosomal Telomeric deletions

More information

Genetic Diseases. SCPA202: Basic Pathology

Genetic Diseases. SCPA202: Basic Pathology Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities

More information

Whole exome sequencing Gene package Epilepsy version 1,

Whole exome sequencing Gene package Epilepsy version 1, Whole Exome Sequencing Gene package Epilepsy, version 1, 8 4 2015 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Comprehensive Test Menu December 2018

Comprehensive Test Menu December 2018 Comprehensive Test Menu December 2018 Cancer brain tumors Brain tumors, hereditary BrainTumorNext: 27 genes 14-21 days 8847 Neurofibromatosis type 2 (NF2) NF2 14-21 days 9024 Schwannomatosis SMARCB1 14-21

More information

General Approach to Genetic Testing

General Approach to Genetic Testing Protocol General Approach to Genetic Testing (20491) (Formerly Genetic Testing for Inherited Disorders) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization Yes Review Dates:

More information

Informed Consent Columbia Whole Genome or Whole Exome Sequencing

Informed Consent Columbia Whole Genome or Whole Exome Sequencing Informed Consent Columbia Whole Genome or Whole Exome Sequencing Please read the following form carefully and discuss with your ordering physician before signing consent. This consent is intended for the

More information

FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY # Colorectal cancer, hereditary nonpolyposis # Meckel syndrome, type 1 #249000

FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY # Colorectal cancer, hereditary nonpolyposis # Meckel syndrome, type 1 #249000 Supplementary Table 1 A randomly selected subset of 100 record pairs crossreferenced by the curators. To be sure the 7,000 cross referenced records in fact were pairs of highly overlapping phenotypes,

More information

Medical Policy. MP Genetic Testing for Epilepsy

Medical Policy. MP Genetic Testing for Epilepsy Medical Policy MP 2.04.109 BCBSA Ref. Policy: 2.04.109 Last Review: 02/26/2018 Effective Date: 02/26/2018 Section: Medicine Related Policies 2.04.81 Genetic Testing for Rett Syndrome 2.04.83 Genetic Testing

More information

Integration of Next-Generation Sequencing into Epilepsy Clinical Care. Michelle Demos University of British Columbia BC Children s Hospital

Integration of Next-Generation Sequencing into Epilepsy Clinical Care. Michelle Demos University of British Columbia BC Children s Hospital Integration of Next-Generation Sequencing into Epilepsy Clinical Care Michelle Demos University of British Columbia BC Children s Hospital No Disclosures Learning Objectives To review: the impact of using

More information

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics

More information

Chromosome 16. Introduction

Chromosome 16. Introduction Chromosome 16 Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University

More information

Investigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies

Investigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies Investigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies Akbar Mohammadzadeh MD, PhD candidate in Medical Genetics Genetics Research Center University

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,

More information

Clinical evaluation of microarray data

Clinical evaluation of microarray data Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray

More information

Appendix B: List of Rare Diseases

Appendix B: List of Rare Diseases Appendix B: List of Rare Diseases Rare caregivers were asked to indicate what rare disease, illness, or condition their care recipient had from a list of over 6,000 potential rare diseases. Below is a

More information

Whole Exome Sequencing (WES): Questions and Answers for Providers

Whole Exome Sequencing (WES): Questions and Answers for Providers Whole Exome Sequencing (WES): Questions and Answers for Providers 1. What is Whole Exome Sequencing?... 2 2. What is the difference between Whole Exome Sequencing (WES) and Whole Exome Sequencing Plus

More information

Classifications of genetic disorders disorders

Classifications of genetic disorders disorders Classifications of genetic disorders Dr. Liqaa M. Sharifi Human diseases in general can roughly be classified in to: 1-Those that are genetically determined. 2-Those that are almost entirely environmentally

More information

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University

Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University 1395 21 مشاوره ژنتیک و نقش آن در پیش گیری از معلولیت ها 20

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): October 1, 2014 Most Recent Review Date (Revised): May 20, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

Preimplantation Genetic Diagnosis for inherited renal diseases

Preimplantation Genetic Diagnosis for inherited renal diseases Preimplantation Genetic Diagnosis for inherited renal diseases 54th ERA-EDTA Congress Madrid, Spain June 3-6, 2017 Nine Knoers Department of Genetics Chronic kidney disease frequently has genetic aetiology

More information